| SEKm | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net sales | 1,694 | 1,794 | 1,727 |
| Sales growth in constant currency | 5.5% | -3.7% | |
| Organic sales growth | 2.5% | -3.3% | |
| Gross profit | 1,184 | 919 | 922 |
| Gross margin | 70% | 51% | 53% |
| OPEX* | -3,455 | -1,585 | -1,264 |
| OPEX % of sales | -204% | -88% | -73% |
| EBITDA | -62 | 283 | 103 |
| EBITDA margin | -4% | 16% | 6% |
| Adjusted EBITDA | 9 | 144 | 141 |
| Adjusted EBITDA margin | 0.5% | 8% | 8% |
| EBIT | -2 171 | -448 | -301 |
| EBIT margin | -128% | -25% | -17% |
| Net income | -3,405 | -1,174 | -9 |
| FTE | 845 | 691 | 635 |
*OPEX 2022, Impairment of goodwill amounted to SEK -1,868m
| SEKm | Life Science Solutions | Lab Automation | Total | Life Science Solutions | Lab Automation | Total | Life Science Solutions | Lab Automation | Total |
|---|---|---|---|---|---|---|---|---|---|
| Financial Year | 2022 | 2022 | 2022 | 2023 | 2023 | 2023 | 2024 | 2024 | 2024 |
| Europe | 422 | 99 | 521 | 416 | 126 | 542 | 390 | 114 | 504 |
| North America | 677 | 233 | 909 | 680 | 291 | 971 | 609 | 450 | 1,058 |
| Asia | 191 | 22 | 213 | 171 | 86 | 257 | 137 | 5 | 142 |
| Rest of the World | 43 | 9 | 51 | 24 | 0 | 24 | 23 | 0 | 23 |
| Total | 1,332 | 362 | 1,694 | 1,291 | 503 | 1,794 | 1,159 | 569 | 1,727 |
